safranal has been researched along with malondialdehyde in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farahmand, SK; Samarghandian, S; Samini, F; Samini, M | 1 |
| Bozkurt, MF; Fıdan, AF; Hazman, Ö; Karafakıoğlu, YS | 1 |
| Delkhosh-Kasmaie, F; Farshid, AA; Imani, M; Tamaddonfard, E | 1 |
| Chu, X; Guan, S; Jin, W; Wang, H; Xue, Y; Zhang, J; Zhang, Y | 1 |
| Feligioni, M; Fotoohi, A; Hassanzadeh, K; Hosseini, S; Izadpanah, E; Moloudi, MR | 1 |
| Alakuş, H; Cellat, M; Etyemez, M; Güvenç, M; İşler, CT; Kutlu, T; Kuzu, M | 1 |
6 other study(ies) available for safranal and malondialdehyde
| Article | Year |
|---|---|
Safranal ameliorates antioxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver.
Topics: Aging; Animals; Antioxidants; Catalase; Cyclohexenes; Glutathione Transferase; Lipid Peroxidation; Liver; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Terpenes | 2013 |
Efficacy of safranal to cisplatin-induced nephrotoxicity.
Topics: Animals; Antineoplastic Agents; Cisplatin; Creatinine; Cyclohexenes; Drug Administration Schedule; Glutathione; Injections, Intraperitoneal; Kidney; Male; Malondialdehyde; Nephritis; Protective Agents; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Terpenes; Urea | 2017 |
The effects of safranal, a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations.
Topics: Animals; Behavior, Animal; Caspase 3; Cell Count; Crocus; Cyclohexenes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hippocampus; Hyperglycemia; Malondialdehyde; Maze Learning; Memory Disorders; Metformin; Neurons; Rats, Wistar; Spatial Learning; Streptozocin; Superoxide Dismutase; Swimming; Task Performance and Analysis; Terpenes; Tumor Necrosis Factor-alpha | 2018 |
Safranal, an active constituent of saffron, ameliorates myocardial ischemia via reduction of oxidative stress and regulation of Ca
Topics: Animals; Calcium; Cardiotonic Agents; Cells, Cultured; Crocus; Cyclohexenes; Disease Models, Animal; Isoproterenol; Male; Malondialdehyde; Myocardial Contraction; Myocardial Ischemia; Myocardium; Oxidative Stress; Phytotherapy; Rats, Sprague-Dawley; Superoxide Dismutase; Terpenes | 2020 |
A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
Topics: Animals; Antioxidants; Behavior, Animal; Body Weight; Catalase; Cerebral Cortex; Cyclohexenes; Glutathione; Huntington Disease; Locomotion; Male; Malondialdehyde; Mastication; Neuroprotective Agents; Nitro Compounds; Propionates; Rats, Wistar; Rotarod Performance Test; Superoxide Dismutase; Terpenes | 2021 |
Investigation of the effects of safranal on the experimentally created rheumatoid arthritis model in rats.
Topics: Alanine; Animals; Antioxidants; Arthritis, Experimental; Arthritis, Rheumatoid; Aspartate Aminotransferases; C-Reactive Protein; Catalase; Creatinine; Cyclohexenes; Cyclooxygenase 2; Freund's Adjuvant; Glutathione; Glutathione Peroxidase; Interleukin-6; Malondialdehyde; Methotrexate; NF-kappa B; Rats; Terpenes; Tumor Necrosis Factor-alpha; Urea | 2022 |